Technical Analysis for BBLG - Bone Biologics Corp
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Upper Bollinger Band Walk | Strength | 0.00% | |
Earnings Movers | Other | 0.00% | |
Upper Bollinger Band Walk | Strength | -3.83% | |
Earnings Movers | Other | -3.83% | |
Upper Bollinger Band Touch | Strength | -3.83% | |
Gapped Down | Weakness | -3.83% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -4.86% | |
Inside Day | Range Contraction | -4.86% | |
BB Squeeze Ended | Range Expansion | -4.86% | |
Gapped Up | Strength | -4.86% |
Alert | Time |
---|---|
Down 5% | about 11 hours ago |
Fell Below Previous Day's Low | about 12 hours ago |
Down 3% | about 13 hours ago |
Possible NR7 | about 13 hours ago |
Possible Inside Day | about 13 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 05/06/2024
Bone Biologics Corp Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. Its platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Biopharmaceutical Clinical Medicine Surgery Neurosurgery Platform Technology Orthopedic Surgery Sports Medicine Surgical Specialties Spinal Fusion Degenerative Disc Disease Spinal Fusion Applications
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 72.0 |
52 Week Low | 1.46 |
Average Volume | 87,072 |
200-Day Moving Average | 4.34 |
50-Day Moving Average | 2.00 |
20-Day Moving Average | 1.67 |
10-Day Moving Average | 1.67 |
Average True Range | 0.18 |
RSI (14) | 47.09 |
ADX | 20.03 |
+DI | 20.60 |
-DI | 16.43 |
Chandelier Exit (Long, 3 ATRs) | 1.47 |
Chandelier Exit (Short, 3 ATRs) | 2.01 |
Upper Bollinger Bands | 1.89 |
Lower Bollinger Band | 1.45 |
Percent B (%b) | 0.71 |
BandWidth | 25.89 |
MACD Line | -0.08 |
MACD Signal Line | -0.14 |
MACD Histogram | 0.0597 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.96 | ||||
Resistance 3 (R3) | 1.96 | 1.89 | 1.92 | ||
Resistance 2 (R2) | 1.89 | 1.84 | 1.89 | 1.91 | |
Resistance 1 (R1) | 1.83 | 1.81 | 1.80 | 1.83 | 1.90 |
Pivot Point | 1.76 | 1.76 | 1.75 | 1.76 | 1.76 |
Support 1 (S1) | 1.70 | 1.71 | 1.66 | 1.69 | 1.62 |
Support 2 (S2) | 1.63 | 1.68 | 1.63 | 1.61 | |
Support 3 (S3) | 1.57 | 1.63 | 1.60 | ||
Support 4 (S4) | 1.56 |